Minoxidil when a hair transplant is on your mind

Summary

You are losing hair and the word minoxidil follows you everywhere: the forums, the pharmacy counter, the dermatologist’s room. It is still the only product applied directly to the scalp whose effect on androgenetic alopecia, inherited baldness, has been measured in properly run trials. It is used badly about as often as it is talked about.

This page sets out what minoxidil does, how long it takes to do it, and what happens the day you stop. And above all the question almost nobody bothers with: what place it deserves when a hair transplant is on the table, or when you have just come out of one.

A blood pressure drug that ended up on scalps

The molecule came out of an American laboratory in the 1950s, where the team was hunting for an ulcer treatment. It never cured a single ulcer. It did prove to be a vasodilator, meaning a substance that widens blood vessels, and on that basis it was licensed in the United States in 1979 as a tablet for severe high blood pressure. Patients on it started growing hair, sometimes in places they had not bargained for. The manufacturer turned that observation around and built a version to be rubbed into the scalp, cleared in 1988 under the brand name Rogaine. It was the first drug ever approved against baldness. That sequence is the American one; every other market picked the product up later, at its own pace.

Bottle of 5 per cent minoxidil scalp solution held in one hand, next to the full chemical structure of the molecule

The topical route has dominated ever since. You put it straight onto the thinning areas, as a solution or as a foam, once or twice a day depending on the presentation. That is the ordinary use, the one your pharmacist knows, and unless we say otherwise it is the only one discussed here.

What it does to the follicle

The mechanism is not fully worked out. The best documented explanation is that minoxidil opens potassium channels inside the cells of the hair follicle, the tiny organ each hair grows out of. That opening stretches the growth phase of the hair cycle and improves the local blood supply. Hair follicles already shrunken by heredity fatten up a little, and the hair that comes back out is thicker and better pigmented.

One detail explains a great deal of disappointment: the molecule you apply is inactive. An enzyme in the scalp, sulfotransferase SULT1A1, has to convert it into minoxidil sulfate before anything happens. That enzyme is not equally busy in everyone. Some patients respond beautifully. Others, with the same bottle and the same discipline, see almost nothing.

Three to six months before you can judge

This is the rule most people never hear. Count on three to six months of daily use before you can say whether the treatment is working, and often twelve months for the full effect. Three weeks proves nothing. Six weeks proves nothing either.

Man using a dropper to apply a hair product along the frontal hairline of his scalp

And what the meta-analyses describe stays modest: minoxidil slows shedding and recovers part of the density recently lost. It does not rebuild hair on an area that has been smooth for years. On the temples its effect is clearly weaker than on the crown. The reviews that rank non-surgical treatments put it behind finasteride in men, but ahead of everything else sold in a chemist.

The initial shed, the moment everyone wants to quit

In the first few weeks, many patients lose hair far more heavily than before. The brush fills up, the shower becomes unpleasant, and giving up starts to look sensible.

Hand holding a hairbrush loaded with a mass of shed hair

The phenomenon has a name, the initial shed, and it is a close relative of telogen effluvium. Minoxidil pushes dormant follicles into a fresh cycle, and to restart they first have to eject the old hair they were still holding. It passes. It usually runs for a few weeks and settles by itself. Stopping at exactly that point means losing the benefit before it has had a chance to exist.

What happens when you stop

Minoxidil cures nothing. It compensates, for as long as you apply it. From the day you stop, the follicles go back to their natural course and the hair you gained falls out again, generally within three to six months. You do not end up worse off than before, but you do end up where you would have been without treatment.

That is a constraint to weigh before starting, not afterwards. A daily treatment carried on for years is a decision you take with your eyes open.

The side effects worth knowing about

Most users tolerate the product well. When problems do turn up, they are mainly skin problems.

Close up of a scalp parted by hand, showing visible skin and sparse hair at the roots

Itching, redness, dryness, small flakes: the alcohol and propylene glycol in some solutions irritate sensitive scalps. Foam formulations contain less of them and are often better tolerated. Irritation that will not settle should be shown to a doctor rather than endured.

Hair appearing where you did not want it

Woman using tweezers to remove fine hair above her upper lip

Fine hair can grow on the forehead or the face, usually through contact with the product or with badly rinsed hands. This effect is both more common and harder to live with in women. It reverses once the treatment stops.

One point is not negotiable: minoxidil is contraindicated in women who are pregnant or breastfeeding, in every form. Hair loss linked to pregnancy is a matter for medical advice, never for self-medication.

Low dose oral minoxidil, an off-label use

For some years now, dermatologists have been prescribing minoxidil tablets at a very low dose for hair loss. This is off-label prescribing: the drug remains officially a blood pressure medicine, it is not sold over the counter for hair, and it is not something to order online.

Overturned bottle labelled minoxidil, spilling white tablets onto a blue background

The use belongs strictly inside a prescription and medical follow-up, with blood pressure and heart rate monitored. The largest series published so far covers 1,404 patients and describes side effects that are mostly mild, dominated by excess body hair. None of that turns oral minoxidil into something to try on your own. If the topical route is not holding, the question belongs in a consultation.

In women

Woman's hand holding a pipette of hair treatment above dark brown hair

Which strength is licensed for women depends on the country and on the formulation. On the British and American markets, the 2 % solution has long been the reference for women, and a 5 % foam applied once a day is also approved for them. The higher strength brings a higher risk of unwanted hair growth, which is precisely why the once-daily foam exists. Frequency, formulation and follow-up are covered in our page on minoxidil in women.

Minoxidil around a hair transplant

This is the question that comes up most in consultation, and the one no patient information leaflet ever touches.

Doctor Cinik examining a patient's scalp in consultation, and the medical team marking out the frontal hairline in theatre

Before: protecting the hair that is still there

A transplant moves hair, it does not create any. Grafts taken from the donor area are genetically insensitive to the hormone behind baldness, so they stay. Your native hair carries on with its own story.

That is the real danger behind a result that ages badly: the transplanted zones hold while the original hair around them retreats. Sooner or later the contrast shows. In a young patient still well short of the advanced stages of the Norwood scale, stabilising the native hair before surgery changes the shape of the following ten years. It is one of the things a surgeon weighs when deciding whether you are suitable for a hair transplant.

In practice, a topical treatment started several months before the operation is not there to improve the result of the transplant itself. It is there to slow down what is happening around it. A patient who arrives stabilised also lets the surgeon design more accurately: when shedding is still active and fast, graft distribution has to anticipate a course nobody can predict yet. None of that gets decided on a shopping site. It gets decided in consultation, with the scalp examined and the family history taken.

After: restarting is the surgeon’s call

Once the operation is done the scalp is fragile, the grafts are settling and crusts form. Putting an alcohol-based product on that skin in the days that follow makes no sense at all. There is no universal delay before restarting: it depends on how healing goes and on what you were using before surgery.

Some surgeons also lean on minoxidil to cushion shock loss, the temporary shedding of native hair triggered by the procedure itself. Others prefer to wait. Either way the decision belongs to the team who operated on you, and we go through the practicalities of minoxidil and finasteride after a hair transplant in a dedicated page. Restarting on your own because a forum said so is the wrong way to do it.

The other options

Box of finasteride 1 mg film-coated tablets, pack of 28

Finasteride works on a different target: it blocks the conversion of testosterone into dihydrotestosterone, the hormone that shrinks follicles in predisposed people. Head-to-head comparisons make it more effective than minoxidil in men. It is taken by mouth, on prescription, and its profile of sexual and mood-related side effects deserves a real medical conversation before the first tablet.

Close up of a saw palmetto palm and capsules of a plant based food supplement

On the botanical side, rosemary oil is the only one with a published comparative trial against minoxidil, run on a small number of participants. Saw palmetto is regularly quoted for its supposed action on DHT, without any scientific consensus behind it. The rest is mostly habit and marketing.

A transplant is still the most durable treatment

Implanter handled by a gloved practitioner on a densely grafted recipient area, and a smiling patient giving a thumbs up the day after surgery

Minoxidil maintains what is still alive. A transplant reintroduces hair where the follicle has gone, using grafts that will not fall out again. It is the most durable treatment for androgenetic alopecia, and the only one that produces a visible result on an area that has already gone bare.

The two do not replace each other. Minoxidil will not give you back a hairline that is already lost. A hair transplant Turkey will not protect the native hair sitting around it. The sensible first move is to have your scalp assessed before committing to anything: that examination is what tells you whether a topical treatment is enough on its own, whether it should run alongside surgery, or whether there is nothing left for it to stabilise.

Sources

Gupta, A. K., Mays, R. R., Dotzert, M. S., Versteeg, S. G., Shear, N. H., et Piguet, V. (2018). Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. Journal of the European Academy of Dermatology and Venereology, 32(12), 2112-2125. https://doi.org/10.1111/jdv.15081

Randolph, M., et Tosti, A. (2021). Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology, 84(3), 737-746. https://doi.org/10.1016/j.jaad.2020.06.1009

Vañó-Galván, S., Pirmez, R., Hermosa-Gelbard, A., Moreno-Arrones, O. M., Saceda-Corralo, D., Rodrigues-Barata, R., Jimenez-Cauhe, J., et Koh, W. (2021). Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology, 84(6), 1644-1651. https://doi.org/10.1016/j.jaad.2021.02.054

Sobral, R. M., Moreira, F. A., Rodrigues, M. A., Rocha, L. B., Pirolla, E. H., et Soares, R. (2025). Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. International Journal of Dermatology, 64(3), 479-484. https://doi.org/10.1111/ijd.17524

Gupta, A. K., Bamimore, M. A., Williams, G., et Talukder, M. (2025). Comparative efficacy of minoxidil and 5-alpha reductase inhibitors monotherapy for male pattern hair loss: network meta-analysis study of current empirical evidence. Journal of Cosmetic Dermatology, 24(7), e70320. https://doi.org/10.1111/jocd.70320